Search results
Found 18 matches for
Oxford Centre for Haematology Day 2024
Department of Oncology MRC MHU NIHR Oxford BRC OCH
5 February 2024
T cell Immunotherapy animation launched
MRC MHU OCH
26 January 2023
A new animation explores work by the Chakraverty Group, Vyas Group, and Professor Borrow from the Jenner Institute.
Patient priorities guide Oxford Myeloma research
OCH RDM
29 March 2022
Medical staff in Oxford are partnering closely with Myeloma patients to help set priorities for future research.
Spin-out company Alethiomics launches
MRC MHU OCH RDM
15 December 2021
The enterprise will focus on developing targeted therapies for a specific family of blood cancers.
Interview with Excellence Award winner Dr Susan Shapiro
OCH RDM
9 December 2021
A member of the Oxford Centre For Haematology, Dr Shapiro, was recently interviewed by the Royal College of Pathologists.
Strong immune responses in myeloma patients after two doses of COVID vaccine
OCH RDM
26 November 2021
New model for infant leukaemia announced
MRC MHU OCH Paediatrics RDM
25 November 2021
The breakthrough could lead to development of new treatments for infant Acute Lymphoblastic Leukaemia.
Focus on racism- making a difference for sickle cell disease
MRC MHU OCH RDM
27 October 2021
Project aims to increase understanding, reduce stigma, and improve the quality of life of people living with sickle cell disease.
Giulia Orlando becomes a John Goldman Fellow
MRC MHU OCH
19 October 2021
Many congratulations to Dr Giulia Orlando, who has become a 2021 Leukaemia UK John Goldman Fellow.
New atlas revealed of bone marrow haematopoiesis during development
MRC MHU OCH Paediatrics
29 September 2021
A new study published this week in Nature, provides the most detailed analysis so far of the prenatal development of blood and immune cells in the bone marrow.
Changes in blood cell production over the human lifetime may hold clues to patterns of disease
Centre for Computational Biology MRC MHU OCH Paediatrics
16 September 2021
A new paper published in Cell Reports reveals that changes in the gene expression of blood stem cells occur across the human lifetime; an important step in the understanding and treatment of blood disorders.
Impaired antibody response to COVID-19 vaccination in patients with myeloid blood cancers
COVID-19 MRC MHU OCH RDM
17 June 2021
New clinical trial for patients affected by blood cancer
MRC MHU OCH RDM
27 May 2021
Radcliffe Department of Medicine's Professor Adam Mead is leading PROMise, a new clinical trial offering a novel treatment option for patients with a type of blood cancer called myelofibrosis.
New funding for early diagnosis research using platelets
MRC MHU OCH RDM
30 March 2021
Dr Bethan Psaila and her team will investigate the potential of circulating blood platelets for early detection of a range of cancer types.
Dr Beth Psaila wins RDM - WIMM Sir Andrew McMichael Award for Excellent Supervision and Mentorship
MRC MHU OCH
24 March 2021
Innovation award for Professor Anindita Roy to develop new treatments for childhood cancer
MRC MHU OCH RDM
18 March 2021
MRC WIMM's Noemi Roy among seven projects awarded Public Engagement Seed Funding 2020-21
MRC MHU OCH
3 February 2021
Dr Noemi Roy has received funding in the 2020-21 round of the Public Engagement with Research Seed Fund as one of seven projects for innovative work to engage the public with medical research.